Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Secondary prevention

Citations 61-70 of 110 total displayed.

Past content (since Mar 1999):

Editorial Commentary
More Evidence of Cardiorenal Protective Effects of Peroxisome Proliferator-Activated Receptor Activation
Ernesto L. Schiffrin
Hypertension published June 20, 2005, doi:10.1161/01.HYP.0000172756.41375.e4 [Abstract]  

Original Articles
Quantitative Coronary Angiogram Analysis: Nifedipine Retard Versus Angiotensin-Converting Enzyme Inhibitors (JMIC-B Side Arm Study)
Eiji Shinoda, Yoshiki Yui, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi, Kazuo Haze, Tetsuya Sumiyoshi, Saichi Hosoda, Chuichi Kawai for the Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group
Hypertension 2005;45:1153-1158; published online before print as doi:10.1161/01.HYP.0000165677.71421.8c [Abstract] [Full text]  

Scientific Contributions
Quantitative Coronary Angiogram Analysis. Nifedipine Retard Versus Angiotensin-Converting Enzyme Inhibitors (JMIC-B Side Arm Study)
Eiji Shinoda, Yoshiki Yui, Kazuhisa Kodama, Atsushi Hirayama, Hiroshi Nonogi, Kazuo Haze, Tetsuya Sumiyoshi, Saichi Hosoda, Chuichi Kawai for the Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group
Hypertension published April 25, 2005, doi:10.1161/01.HYP.0000165677.71421.8c [Abstract]  

Original Articles
Dietary Linolenic Acid Is Associated With a Lower Prevalence of Hypertension in the NHLBI Family Heart Study
Luc Djoussé, Donna K. Arnett, James S. Pankow, Paul N. Hopkins, Michael A. Province, and R. Curtis Ellison
Hypertension 2005;45:368-373; published online before print as doi:10.1161/01.HYP.0000154679.41568.e6 [Abstract] [Full text]  

Scientific Contributions
Dietary Linolenic Acid Is Associated With a Lower Prevalence of Hypertension in the NHLBI Family Heart Study
Luc Djoussé, Donna K. Arnett, James S. Pankow, Paul N. Hopkins, Michael A. Province, and R. Curtis Ellison
Hypertension published January 17, 2005, doi:10.1161/01.HYP.0000154679.41568.e6 [Abstract]  

Scientific Contributions
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study
Jorge R. Kizer, Björn Dahlöf, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H. Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Kristian Wachtell, Jonathan M. Edelman, Steven M. Snapinn, Katherine E. Harris, and Richard B. Devereux
Hypertension 2005;45:46-52; published online before print as doi:10.1161/01.HYP.0000151324.05355.1c [Abstract] [Full text]  

Scientific Contributions
Stroke Reduction in Hypertensive Adults with Cardiac Hypertrophy Randomized to Losartan Versus Atenolol. The Losartan Intervention For Endpoint Reduction in Hypertension Study
Jorge R. Kizer, Björn Dahlöf, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristianson, Ole Lederballe-Pedersen, Lars H. Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Kristian Wachtell, Jonathan M. Edelman, Steven M. Snapinn, Katherine E. Harris, and Richard B. Devereux
Hypertension published December 6, 2004, doi:10.1161/01.HYP.0000151324.05355.1c [Abstract]  

Brief Reviews
Hormone Replacement Therapy and Cardiovascular Disease: What Went Wrong and Where Do We Go From Here?
Raghvendra K. Dubey, Bruno Imthurn, Lefteris C. Zacharia, and Edwin K. Jackson
Hypertension 2004;44:789-795; published online before print as doi:10.1161/01.HYP.0000145988.95551.28 [Abstract] [Full text]  

Editorial Commentaries
Alcohol-Associated Hypertension: When One Drinks Makes a Difference
Arthur L. Klatsky
Hypertension 2004;44:805-806; published online before print as doi:10.1161/01.HYP.0000146538.26193.60 [Full text]  

Scientific Contributions
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study
George L. Bakris, Efrain Gaxiola, Franz H. Messerli, Giuseppe Mancia, Serap Erdine, Rhonda Cooper-DeHoff, Carl J. Pepine for the INVEST Investigators
Hypertension 2004;44:637-642; published online before print as doi:10.1161/01.HYP.0000143851.23721.26 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11

* Subspecialty Collections Home

* Show  Secondary prevention
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment